Dramatic study results point to the potential for a steroid-sparing option for patients with the underrecognized multiorgan ...

We recently compiled a list of the 10 Best Immunotherapy Stocks to Buy Now. In this article, we are going to take a look at ...

Amgen (AMGN) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

On November 13, 2024, Amgen filed a BPCIA complaint in the District Court for the Eastern District of North Carolina against Accord Biopharma, Inc.; Accord Healthcare, Inc.; and Intas Pharmaceuticals, ...

In the ongoing case of Carefirst of Maryland Inc. v. Johnson & Johnson, the plaintiffs successfully overcame a motion to dismiss. At the heart of ...

Northern Irelands Tom McKibbin claimed the last of the 10 PGA Tour cards on offer via the Race to Dubai rankings and will ...

Over 2 decades ago, the aldosterone antagonist eplerenone proved beneficial after MI complicated by left ventricular ...

Patients with GPA completely weaned off glucocorticoids were four times as likely to flare compared with those kept on a low ...

Barclays analyst Carter Gould maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today and set a price target of $975.00.

The Dow Jones Industrial Average is declining Monday morning with shares of Nike and NVIDIA Corp. delivering the stiffest headwinds for the index. The Dow was most recently trading 111 points, or 0.3% ...

Wolfe Research has recently initiated Amgen Inc (AMGN) stock to Peer Perform rating, as announced on November 15, 2024, according to Finviz. Earlier, on November 14, 2024, Citigroup had initiated the ...

Wall Street experienced mixed trading as investors awaited Nvidia's earnings report, a key indicator for the AI sector's ...